Article
Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis.
Science (New York, N.Y.) - 14 Jun 1996
Sherman D R, Mdluli K, Hickey M J, Arain T M, Morris S L, Barry C E, Stover C K
Abstract excerpt
Mutations that eliminate KatG catalase-peroxidase activity prevent activation of isoniazid and are a major mechanism of resistance to this principal drug for the treatment of Mycobacterium tuberculosis infections. However, the loss of KatG activity in clinical isolates seemed paradoxical because...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
